149 related articles for article (PubMed ID: 38505031)
1. Characteristics and patient-reported outcomes of long-term lung cancer survivors.
Fonseca A; Antunes M; Firmino-Machado J; Barroso A; Dias M
J Thorac Dis; 2024 Feb; 16(2):1087-1096. PubMed ID: 38505031
[TBL] [Abstract][Full Text] [Related]
2. Quality of Life in NSCLC Survivors - A Multicenter Cross-Sectional Study.
Hechtner M; Eichler M; Wehler B; Buhl R; Sebastian M; Stratmann J; Schmidberger H; Gohrbandt B; Peuser J; Kortsik C; Nestle U; Wiesemann S; Wirtz H; Wehler T; Bals R; Blettner M; Singer S
J Thorac Oncol; 2019 Mar; 14(3):420-435. PubMed ID: 30508641
[TBL] [Abstract][Full Text] [Related]
3. Quality of life and symptom burden among long-term lung cancer survivors.
Yang P; Cheville AL; Wampfler JA; Garces YI; Jatoi A; Clark MM; Cassivi SD; Midthun DE; Marks RS; Aubry MC; Okuno SH; Williams BA; Nichols FC; Trastek VF; Sugimura H; Sarna L; Allen MS; Deschamps C; Sloan JA
J Thorac Oncol; 2012 Jan; 7(1):64-70. PubMed ID: 22134070
[TBL] [Abstract][Full Text] [Related]
4. Evaluating quality of life and pulmonary function of long-term survivors of non-small cell lung cancer treated with radical or postoperative radiotherapy.
Ozturk A; Sarihan S; Ercan I; Karadag M
Am J Clin Oncol; 2009 Feb; 32(1):65-72. PubMed ID: 19194128
[TBL] [Abstract][Full Text] [Related]
5. A study of modifiable factors associated with health-related quality of life in long-term cervical cancer survivors.
Dahl AA; Bentzen AG; Fosså SD; Hess SL; Kiserud CE
Acta Obstet Gynecol Scand; 2023 Feb; 102(2):218-225. PubMed ID: 36683549
[TBL] [Abstract][Full Text] [Related]
6. Quality of life in long-term survivors of oropharynx carcinoma.
Pourel N; Peiffert D; Lartigau E; Desandes E; Luporsi E; Conroy T
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):742-51. PubMed ID: 12377326
[TBL] [Abstract][Full Text] [Related]
7. Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study.
Hui R; Özgüroğlu M; Villegas A; Daniel D; Vicente D; Murakami S; Yokoi T; Chiappori A; Lee KH; de Wit M; Cho BC; Gray JE; Rydén A; Viviers L; Poole L; Zhang Y; Dennis PA; Antonia SJ
Lancet Oncol; 2019 Dec; 20(12):1670-1680. PubMed ID: 31601496
[TBL] [Abstract][Full Text] [Related]
8. Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial.
Velikova G; Morden JP; Haviland JS; Emery C; Barrett-Lee P; Earl H; Bloomfield D; Brunt AM; Canney P; Coleman R; Verrill M; Wardley A; Bertelli G; Ellis P; Stein R; Bliss JM; Cameron D;
Lancet Oncol; 2023 Dec; 24(12):1359-1374. PubMed ID: 37926100
[TBL] [Abstract][Full Text] [Related]
9. Quality of life in lung cancer survivors treated with tyrosine-kinase inhibitors (TKI): results from the multi-centre cross-sectional German study LARIS.
Riccetti N; Blettner M; Taylor K; Wehler B; Gohrbandt B; Nestle U; Bals R; Stockinger M; Wehler T; Singer S; Eichler M
J Cancer Res Clin Oncol; 2022 Aug; 148(8):1943-1953. PubMed ID: 35608689
[TBL] [Abstract][Full Text] [Related]
10. Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Garassino MC; Gadgeel S; Esteban E; Felip E; Speranza G; Domine M; Hochmair MJ; Powell S; Cheng SY; Bischoff HG; Peled N; Reck M; Hui R; Garon EB; Boyer M; Wei Z; Burke T; Pietanza MC; Rodríguez-Abreu D
Lancet Oncol; 2020 Mar; 21(3):387-397. PubMed ID: 32035514
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life among cervical cancer survivors at a tertiary hospital in Ghana.
Amo-Antwi K; Agambire R; Konney TO; Nguah SB; Dassah ET; Nartey Y; Appiah-Kubi A; Tawiah A; Tannor EK; Peprah A; Ansah MB; Sam D; Akakpo PK; Ankobea F; Djokoto RM; Idun MYK; Opare-Addo HS; Opoku BK; Odoi AT; Johnston C
PLoS One; 2022; 17(6):e0268831. PubMed ID: 35657957
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Patient-Reported Quality of Life of Anal Cancer Survivors Treated With Intensity Modulated Radiation Therapy and Concurrent Chemotherapy: Results From a Prospective Phase II Trial.
Joseph K; Balushi MA; Ghosh S; Stenson T; Abraham A; Elangovan A; Warkentin H; Paulson K; Tankel K; Usmani N; Severin D; Schiller D; Wong C; Mulder K; Doll C; King K; Nijjar T
Int J Radiat Oncol Biol Phys; 2023 Oct; 117(2):434-445. PubMed ID: 37148982
[TBL] [Abstract][Full Text] [Related]
13. Impact of Non-guideline-directed Care on Quality of Life in Testicular Cancer Survivors.
Saoud RM; Andolfi C; Aizen J; Wymer K; Burg M; Barashi N; Daneshmand S; Eggener S
Eur Urol Focus; 2021 Sep; 7(5):1137-1142. PubMed ID: 33121935
[TBL] [Abstract][Full Text] [Related]
14. The Overall Quality of Life and Oncological Outcomes Following Radical Hysterectomy in Cervical Cancer Survivors Results from a Large Long-Term Single-Institution Study.
Stanca M; Căpîlna DM; Trâmbițaș C; Căpîlna ME
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053481
[TBL] [Abstract][Full Text] [Related]
15. Clinically Important Reductions in Physical Function and Quality of Life in Adults with Tumor Prostheses in the Hip and Knee: A Cross-sectional Study.
Fernandes L; Holm CE; Villadsen A; Sørensen MS; Zebis MK; Petersen MM
Clin Orthop Relat Res; 2021 Oct; 479(10):2306-2319. PubMed ID: 33974591
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
[TBL] [Abstract][Full Text] [Related]
17. Impact of lorlatinib on patient-reported outcomes in patients with advanced ALK-positive or ROS1-positive non-small cell lung cancer.
Peters S; Shaw AT; Besse B; Felip E; Solomon BJ; Soo RA; Bearz A; Gadgeel SM; Lin CC; Kao S; Seto T; Masters ET; Abbattista A; Clancy JS; Thurm H; Reisman A; Peltz G; Ross Camidge D
Lung Cancer; 2020 Jun; 144():10-19. PubMed ID: 32344248
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal changes of health-related quality of life over 10 years in breast cancer patients treated with radiotherapy following breast-conserving surgery.
Gao Y; Rosas JC; Fink H; Behrens S; Chang-Claude J; Seibold P
Qual Life Res; 2023 Sep; 32(9):2639-2652. PubMed ID: 37093543
[TBL] [Abstract][Full Text] [Related]
19. Quality of life, distress, anxiety and depression of ambulatory cancer patients receiving chemotherapy.
Papadopoulou A; Govina O; Tsatsou I; Mantzorou M; Mantoudi A; Tsiou C; Adamakidou T
Med Pharm Rep; 2022 Oct; 95(4):418-429. PubMed ID: 36506609
[TBL] [Abstract][Full Text] [Related]
20. Health-Related Quality of Life and Thyroid Cancer-Specific Symptoms in Patients Treated for Differentiated Thyroid Cancer: A Single-Center Cross-Sectional Survey from Mainland China.
Chen C; Cao J; Wang Y; Han X; Zhang Y; Zhuang S
Thyroid; 2023 Apr; 33(4):474-483. PubMed ID: 36792949
[No Abstract] [Full Text] [Related]
[Next] [New Search]
